INOVIO PHARMACEUTICALS, INC. (INO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $48.4K2010: $181.6K2011: $161.2K2012: $241.0K2013: $176.9K2014: $1.38M2015: $2.78M2016: $2.74M2017: $10.29M2018: $2.09M2019: $987.9K2020: $1.52M2021: $1.23M2022: $969.2K2023: $320.9K2024: $487.8K2025: $285.7K$285.7K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$285.7K-41.4%
2024$487.8K+52.0%
2023$320.9K-66.9%
2022$969.2K-21.3%
2021$1.23M-19.0%
2020$1.52M+53.9%
2019$987.9K-52.6%
2018$2.09M-79.7%
2017$10.29M+275.9%
2016$2.74M-1.5%
2015$2.78M+101.6%
2014$1.38M+680.0%
2013$176.9K-26.6%
2012$241.0K+49.5%
2011$161.2K-11.3%
2010$181.6K+275.6%
2009$48.4K